Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (22)

2023

  1. Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

    Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057

  2. Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

    Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2069-2083

  3. Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial

    Heart rhythm, Vol. 20, Núm. 6, pp. 822-830

2022

  1. Bone marrow activation in response to metabolic syndrome and early atherosclerosis

    European Heart Journal, Vol. 43, Núm. 19, pp. 1809-1828

  2. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

    European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103

  3. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058

  4. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412

  5. New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume

    JACC: Cardiovascular Imaging, Vol. 15, Núm. 6, pp. 1124-1135

2021

  1. 2020 Update of the quality indicators for acute myocardial infarction: A position paper of the Association for Acute Cardiovascular Care: The study group for quality indicators from the ACVC and the NSTE-ACS guideline group

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 224-233

  2. Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

    Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791

  3. Triglycerides and Residual Atherosclerotic Risk

    Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041

2020

  1. A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart

    Cell, Vol. 183, Núm. 1, pp. 94-109.e23

  2. Association Between Body Size Phenotypes and Subclinical Atherosclerosis

    The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 12

  3. Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals

    Journal of the American College of Cardiology, Vol. 76, Núm. 14, pp. 1674-1685

  4. Short-Term Progression of Multiterritorial Subclinical Atherosclerosis

    Journal of the American College of Cardiology, Vol. 75, Núm. 14, pp. 1617-1627

2019

  1. Association of Sleep Duration and Quality With Subclinical Atherosclerosis

    Journal of the American College of Cardiology, Vol. 73, Núm. 2, pp. 134-144

  2. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI

    Journal of the American College of Cardiology, Vol. 73, Núm. 12, pp. 1371-1382

2018

  1. Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: Viewpoint of the task force

    European Heart Journal

  2. Wytyczne ESC dotyczące postępowania w ostrym zawale serca z uniesieniem odcinka ST w 2017 roku

    Kardiologia polska, Vol. 76, Núm. 2, pp. 229-313

2017

  1. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors

    Journal of the American College of Cardiology, Vol. 70, Núm. 24, pp. 2979-2991